Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

NCT03769766 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

291

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Curcumin
DRUG: Placebo

Sponsor

University of Texas Southwestern Medical Center